GLG News by Cosmetic Dermatologists in Private Practice (US)
Request a free trial
August 5, 2008
IT'S A SHAME!
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Skin care encompasses cosmetic procedures. But those cosmetic procedures should not take priority over the medical conditions - especially since dermatologists are uniquely qualified to treat them. I didn't go to medical school, a residency in medicine, and a fellowship in dermatology to...
August 4, 2008
there are some, but basics in dermatology are why we are good at the cosmetics
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
1. Dermatologists need to keep the basics in dermatology2. The net return on cosmetics is much better than the net return3. It is important to create a balance that gives an opportunity for dermatology patients while treating cosmetics.4.It may be that many dermatologists are still new in cosmetics.5....
August 1, 2008Will access to dermatology care suffer with increased cosmetic procedures ?
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it describes a growing trend among dermatologists to offer a higher level of "customer service" for their cash paying cosmetic patients. This has contributed in a small way to the long waits for non cosmetic dermatology patients to be able to see a dermatologist....
July 21, 2008
Doctors are in the middle of a large financial battle.
Analysis of: Pricey Drugs Put Squeeze on Doctors | online.wsj.com
Author: GLG Expert Contributor
Analysis of: Pricey Drugs Put Squeeze on Doctors | online.wsj.com
Author: GLG Expert Contributor
Unfortunately, the physicians have to buy the drugs and it pits the docs in the middle of the money war of pharmaceuticals. The battle in between is getting too rough and expensive.
July 18, 2008Will prescription drug spending decreases affect dermatology?
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it describes a worrying trend for branded pharmaceutical companies. As copays for branded products go up and the patients economic status worsens, the use of these drugs will fall. This may be especially true for medications in dermatology, where the perceived...
July 7, 2008Protopic use can prevent relapse
Analysis of: Intermittent tacrolimus Ointment therapy Helps Prevent Relapse Of Stabilized Atpoic Dermatitis | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it confirms a commonly used method in clinical dermatology practice. Namely that of using Protopic for longer term maintenance to prevent flares, and to act as a topical steroid sparing agent. This has been done since the introduction of Protopic, and among dermatologists...
July 7, 2008New uses for old meds- benefit or drawback?
Analysis of: One drug, many uses. Good idea? | www.indystar.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important because it describes a growing concern that is not well known to the investment community or the public. Due to increased pressure from the generic companies, the FDA, and the public many companies are finding new uses for older medications. This is very true in dermatology...
July 2, 2008Evolence Approval- what effect will it have on the filler market
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important because it outlines the rationale and benefits of the new collagen based filler from Ortho-Neutrogena/ Johnson and Johnson. This filler appears to last at least 6 months, and does not require pre testing as other collagen based fillers have needed in the past. The fact that...
July 2, 2008
Concerns about Evolence being successful.
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: GLG Expert Contributor
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: GLG Expert Contributor
Here are the concerns.1. The collagen injections by Collagen Corp could not compete with hyaluronic acid because it typically does not last longer. Typically, collagen does not last as long in certain facial regions.2. There are structural changes that would have to be done on collagen to...
June 27, 2008Adolesecnt acne treatable
Analysis of: What Skin Care Routines and Treatments Are Effective for Adolescent Acne? | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that, for the most part , it describes a basic therapeutic regimen for adolescent acne patients. The only error is describing the inflamed lesions as "infections." Acne is predominantly an inflammatory condition, not an infectious one, though a bacteria is involved...
Page : 1 2 3 4 5 6 7 8 Next1 to 10 of 73
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
FDA Alert: Hemorrhagic or Necrotizing Pancreatitis in Patients Taking Byetta
www.fda.gov
Healthways' Guidance Not So Healthy
www.forbes.com
Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise
www.nytimes.com
Hospital Death Rates Unveiled for First-Time Comparison
www.usatoday.com
Temozolomide And Thalidomide Combination Effective Against Malignant Melanoma Spread To CNS And White Blood Cell Count May Be Prognostic
www.medicalnewstoday.com
Dangers of Methadone Usage
August 28, 2008
Its all about the spin
August 21, 2008
Byetta sale will reduce after FAD alert
August 19, 2008
PCI numbers will not drop after Courage
August 19, 2008
Bad News (but not new news) for stents.
August 19, 2008

